12 Health Care Stocks Moving In Thursday's Intraday Session

Author: Benzinga Insights | September 28, 2023 01:31pm

Gainers

• Bionomics (NASDAQ:BNOX) stock increased by 261.4% to $3.56 during Thursday's regular session. As of 13:30 EST, Bionomics's stock is trading at a volume of 94.1 million, which is 38818.0% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $29.0 million.
• Baudax Bio (NASDAQ:BXRX) stock rose 74.26% to $0.52. Trading volume for Baudax Bio's stock is 145.1 million as of 13:30 EST. This is 6961.2% of its average full-day volume over the last 100 days. The company's market cap stands at $4.7 million.
• Femasys (NASDAQ:FEMY) shares increased by 41.45% to $1.57. As of 13:30 EST, Femasys's stock is trading at a volume of 27.4 million, which is 419.7% of its average full-day volume over the last 100 days. The company's market cap stands at $23.6 million.
• Axcella Health (NASDAQ:AXLA) shares increased by 26.62% to $8.75. The current volume of 5.1 million shares is 622.9% of Axcella Health's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $25.7 million.
• Organogenesis Hldgs (NASDAQ:ORGO) stock rose 25.84% to $3.33. The current volume of 2.7 million shares is 332.0% of Organogenesis Hldgs's average full-day volume over the last 100 days (last updated at 13:30 EST). The market value of their outstanding shares is at $437.9 million.
• Aytu BioPharma (NASDAQ:AYTU) stock moved upwards by 25.52% to $2.41. As of 13:30 EST, Aytu BioPharma's stock is trading at a volume of 5.4 million, which is 17269.9% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $13.3 million. The company's, Q4 earnings came out yesterday.

Losers

• Brainstorm Cell (NASDAQ:BCLI) stock fell 55.3% to $0.19 during Thursday's regular session. Trading volume for this security as of 13:30 EST is 4.1 million, which is 1080.6% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $8.5 million.
• Renalytix (NASDAQ:RNLX) shares fell 20.16% to $1.56. The current volume of 326.0K shares is 50.6% of Renalytix's average full-day volume over the last 100 days (last updated at 13:30 EST). The company's market cap stands at $74.3 million. As per the press release, Q4 earnings came out today.
• Sharps Technology (NASDAQ:STSS) shares decreased by 15.79% to $0.48. As of 13:30 EST, Sharps Technology's stock is trading at a volume of 809.5K, which is 295.3% of its average full-day volume over the last 100 days. The company's market cap stands at $5.5 million.
• ACADIA Pharmaceuticals (NASDAQ:ACAD) shares decreased by 13.9% to $22.02. Trading volume for this security as of 13:30 EST is 4.4 million, which is 259.3% of its average full-day volume over the last 100 days. The company's market cap stands at $3.6 billion.
• Avalo Therapeutics (NASDAQ:AVTX) shares decreased by 13.76% to $0.15. Trading volume for this security as of 13:30 EST is 56.4 million, which is 118.8% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $2.9 million.
• Biophytis (NASDAQ:BPTS) shares fell 13.73% to $1.26. Trading volume for this security as of 13:30 EST is 325.4K, which is 21.5% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $6.7 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: ACAD AVTX AXLA AYTU BCLI BNOX BPTS BXRX FEMY ORGO RNLX STSS